Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new platform revision label Revision: v3.5.4 was added, replacing the previous Revision: v3.5.3. This indicates a backend deployment update with no change to the page content or study details.
    Difference
    0.0%
    Check dated 2026-05-15T13:51:51.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:09:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:39:30.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:13:35.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:23:31.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the prior government funding status notice (v3.4.1) was removed. The core study details and data remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T12:22:43.000Z thumbnail image

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.